Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Adenosine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA3 known ✓ | P0DMS8 | 4/20 | 1.00 |
| ▸ | ADORA2A known ✓ | P29274 | 1/20 | 1.00 |
| ▸ | ADORA2B known ✓ | P29275 | 1/20 | 1.00 |
| ▸ | ADORA1 known ✓ | P30542 | 1/20 | 1.00 |
| ▸ | DPP4 | P27487 | 1/20 | 1.00 |
| ▸ | MEN1 | O00255 | 1/20 | 1.00 |
| ▸ | SLC28A1 | O00337 | 1/20 | 1.00 |
| ▸ | MAP3K7 | O43318 | 1/20 | 1.00 |
| ▸ | SLC28A2 | O43868 | 1/20 | 1.00 |
| ▸ | GAPDH | P04406 | 1/20 | 1.00 |
| ▸ | MAPK1 | P28482 | 1/20 | 1.00 |
| ▸ | STAT6 | P42226 | 1/20 | 1.00 |
| ▸ | PI4KA | P42356 | 1/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 1/20 | 1.00 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 1.00 |
| ▸ | PI4K2B | Q8TCG2 | 1/20 | 1.00 |
| ▸ | DOT1L | Q8TEK3 | 1/20 | 1.00 |
| ▸ | SLC29A1 | Q99808 | 1/20 | 1.00 |
| ▸ | PI4K2A | Q9BTU6 | 1/20 | 1.00 |
| ▸ | SLC28A3 | Q9HAS3 | 1/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Adenosine SCHEMBL12352425 | 1.00 | ADORA3 (1.00) | ADORA3DPP4MEN1SLC28A1MAP3K7 | |
| Adenosine SCHEMBL1821276 | 1.00 | ADORA3 (1.00) | ADORA3DPP4MEN1SLC28A1MAP3K7 | |
| Adenosine SCHEMBL4522263 | 1.00 | ADORA3 (1.00) | ADORA3DPP4MEN1SLC28A1MAP3K7 | |
| Adenosine SCHEMBL13362239 | 1.00 | ADORA3 (1.00) | ADORA3DPP4MEN1SLC28A1MAP3K7 | |
| Adenosine SCHEMBL24538665 | 1.00 | ADORA3 (1.00) | ADORA3DPP4MEN1SLC28A1MAP3K7 | |
| Adenosine SCHEMBL2228590 | 1.00 | ADORA3 (1.00) | ADORA3DPP4MEN1SLC28A1MAP3K7 | |
| Adenosine SCHEMBL23804425 | 1.00 | ADORA3 (1.00) | ADORA3DPP4MEN1SLC28A1MAP3K7 | |
| Adenosine SCHEMBL406207 | 1.00 | ADORA3 (1.00) | ADORA3DPP4MEN1SLC28A1MAP3K7 | |
| Adenosine SCHEMBL23420216 | 1.00 | ADORA3 (1.00) | ADORA3DPP4MEN1SLC28A1MAP3K7 | |
| Adenosine SCHEMBL2403819 | 1.00 | ADORA3 (1.00) | ADORA3DPP4MEN1SLC28A1MAP3K7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 250969 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260144737-A1 | Care and/or Make-Up Composition for Keratin Materials Comprising at Least One Volatile Solvent, a Particular Polyester and a Colorant | L'OREAL (FR) | 2026-05-28 | — | — | US | claimed |
| US-20260144829-A1 | SYNBIOTIC COMPOSITION, METABOLITES, AND METHOD OF PREVENTING AND TREATING OBESITY-RELATED DISEASE | Hsu, Cheng-Chih (TW) | 2026-05-28 | — | — | US | claimed |
| US-20260146229-A1 | PHOTORECEPTOR PRECURSOR CELL (PRP) COMPOSITIONS AND USES THEREOF | BLUEROCK THERAPEUTICS LP (US) | 2026-05-28 | — | — | US | claimed |
| US-20260146249-A1 | ANTISENSE OLIGONUCLEOTIDES FOR TREATING A DISEASE OR CONDITION ASSOCIATED WITH AN ABNORMAL PROCESSING OF APP | VICO THERAPEUTICS B.V. (NL) | 2026-05-28 | — | — | US | claimed |
| US-20260144879-A1 | ANTI-VIRAL AND HEPATIC-TARGETED DRUGS | AI-BIOPHARMA (FR) | 2026-05-28 | — | — | US | claimed |
| US-20260144893-A1 | COMPOSITIONS AND METHODS COMPRISING PROGRAMMABLE SNRNAS FOR RNA EDITING | REGENERON PHARMACEUTICALS, INC. (US) | 2026-05-28 | — | — | US | claimed |
| EP-4748942-A1 | SPATIAL TRANSCRIPTOME DETECTION IN TISSUE USING ROLONY TAGGING | Miltenyi Biotec B.V. & Co. KG (DE) | 2026-05-27 | — | — | EP | claimed |
| EP-4747627-A1 | METHODS AND SYSTEMS FOR PREDICTIVE CLASSIFICATION BY MASS SPECTROMETRY AND TRAINED LARGE SPECTRAL MODELS | Matterworks Inc (US) | 2026-05-27 | — | — | EP | claimed |
| EP-4747384-A1 | DUX4-TARGETING ENGINEERED GUIDE RNAS AND POLYNUCLEOTIDES | Shape Therapeutics Inc. (US) | 2026-05-27 | — | — | EP | claimed |
| CN-122081155-A | Pediococcus acidilactici TC-4 capable of degrading nucleoside, purine and uric acid simultaneously and application thereof | — | 2026-05-26 | — | — | CN | claimed |
| US-4213893-A | Flavin adenine dinucleotide-labeled conjugates for use in specific binding assays | MILES LABORATORIES, INC. (US) | 1980-07-22 | — | — | US | claimed |
| US-4210746-A | Nucleotide inhibitor of protein synthesis | NATIONAL RESEARCH DEVELOPMENT CORPORATION (GB) | 1980-07-01 | — | — | US | claimed |
| US-4199498-A | Macromolecularized adenine derivatives | SNAMPROGETTI S.P.A. (IT) | 1980-04-22 | — | — | US | claimed |
| US-4189536-A | BULKING AGENT OF ALBUMIN, GLYCINE, TAURINE, AND THE TRIS(HYDROXYMETHYL)AMINOMETHANE SALT OF MERCAPTOSUCCINIC ACID, DETERMINATION OF SERUM GLUCOSE AND UREA | HYCEL, INC. (US) | 1980-02-19 | — | — | US | claimed |
| US-4088756-A | TREATING PSORIASIS, DERMATITIS WITH ADRENERGIC AGENTS AND HYPOGLYCEMIC AGENTS | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 1978-05-09 | — | — | US | claimed |
| US-4061828-A | Modified, grafted mineral carriers | RHONE-POULENC INDUSTRIES (FR) | 1977-12-06 | — | — | US | claimed |
| US-4059487-A | Purine nucleoside 5'-phosphate (mono, di or tri) 3'(2')-diphosphates and processes for their preparation | SANRAKU-OCEAN CO., LTD. (JA) | 1977-11-22 | — | — | US | claimed |
| US-4016262-A | ANTILIPOLYTIC, HYPERLIPEMIA, ANTICHOLESTEROL AGENTS | BOEHRINGER MANNHEIM G.M.B.H. (DT) | 1977-04-05 | — | — | US | claimed |
| US-3966916-A | ANTILIPOLYTIC, ANTILIPEMIC, ANTICHOLESTEROL | BOEHRINGER MANNHEIM G.M.B.H. (DT) | 1976-06-29 | — | — | US | claimed |
| US-3933592-A | ADENOSINE TRIPHOSPHATE, LUCIFERIN, LUCIFERASE, AND A CATION | HAZLETON LABORATORIES, INCORPORATED (US) | 1976-01-20 | — | — | US | claimed |